Cocaine binding to the Fab fragment of a humanized anti-cocaine mAb quantitated by dye absorption and fluorescence spectroscopy.
Antibodies, Monoclonal, Humanized
/ immunology
Antibody Specificity
Cocaine
/ immunology
Cocaine-Related Disorders
/ blood
Fluorescent Dyes
/ chemistry
Humans
Immunoglobulin Fab Fragments
/ immunology
Ligands
Predictive Value of Tests
Protein Binding
Pyridinium Compounds
/ chemistry
Spectrometry, Fluorescence
Substance Abuse Detection
Absorption spectroscopy
Cocaine antigen binding
DASPMI rotor dye
Fab fragment
Fluorescence spectroscopy
Monoclonal antibody
Journal
Journal of immunological methods
ISSN: 1872-7905
Titre abrégé: J Immunol Methods
Pays: Netherlands
ID NLM: 1305440
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
30
03
2021
revised:
13
07
2021
accepted:
16
07
2021
pubmed:
24
7
2021
medline:
9
11
2021
entrez:
23
7
2021
Statut:
ppublish
Résumé
In this work, we establish that cocaine binding to the Fab fragment of a recombinant humanized anti-cocaine mAb (h2E2) can be directly and easily quantitated using simple and inexpensive absorption and fluorescence measurements, employing dyes typically used for differential scanning fluorimetry, DASPMI and SYPRO Orange. For concentrated samples of the Fab fragment, absorbance spectroscopy employing these dyes reveals the number of cocaine sites present, using either DASPMI (by measuring the increase in dye absorbance) or SYPRO Orange (by measuring the change in dye maximal absorbance wavelength). Interestingly, we observed that cocaine binding to the Fab fragment had a much different effect on the SYPRO Orange dye absorbance than previously reported for the intact h2E2 mAb, resulting in a large decrease in the total dye absorbance for the Fab fragment, in contrast to previous results with the intact h2E2 mAb. For dilute samples of Fab fragment, a dye fluorescence emission spectroscopy assay was developed to quantitate the number of cocaine (and other high affinity cocaine metabolites) binding sites via the ligand-induced decrease in fluorescence emission of both of these extrinsic dyes. The difference in the cocaine titrations for the high affinity (Kd < 30 nM) ligands, cocaine, cocaethylene and benzoylecgonine and the low affinity (Kd > 30 μM) ligands, norcocaine, ecgonine methyl ester, and ecgonine were obvious using this assay. These simple, direct, and inexpensive techniques should prove useful for evaluation of other small molecule antigen binding Fab fragments, enabling quantitation and rapid biochemical assessments necessary for determining Fab fragment suitability for in vivo uses and other assays and experiments.
Identifiants
pubmed: 34298065
pii: S0022-1759(21)00148-4
doi: 10.1016/j.jim.2021.113103
pmc: PMC8338881
mid: NIHMS1727752
pii:
doi:
Substances chimiques
Antibodies, Monoclonal, Humanized
0
Fluorescent Dyes
0
Immunoglobulin Fab Fragments
0
Ligands
0
Pyridinium Compounds
0
2-(4-(dimethylamino)styryl)-1-methylpyridinium
2156-29-8
Cocaine
I5Y540LHVR
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
113103Subventions
Organisme : NIDA NIH HHS
ID : U01 DA039550
Pays : United States
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.
Références
Biochem Biophys Res Commun. 2021 Jan 8;535:93-98
pubmed: 33348081
J Immunol Methods. 2020 Jan;476:112676
pubmed: 31634480
Biochem Biophys Res Commun. 2016 Nov 25;480(4):752-757
pubmed: 27983990
J Pharm Sci. 2013 Aug;102(8):2471-83
pubmed: 23754479
Biochem Biophys Res Commun. 2018 Sep 5;503(2):944-949
pubmed: 29932917
Biochem Biophys Res Commun. 2020 Dec 10;533(3):580-585
pubmed: 32988582
Acta Crystallogr F Struct Biol Commun. 2019 Nov 1;75(Pt 11):697-706
pubmed: 31702583
J Biomol Screen. 2016 Sep;21(8):842-50
pubmed: 27138878
Int Immunopharmacol. 2014 Dec;23(2):387-90
pubmed: 25445957
Biochem Biophys Res Commun. 2017 Jun 3;487(3):690-694
pubmed: 28442345
Biochem Biophys Res Commun. 2016 Aug 26;477(3):363-8
pubmed: 27342663
Pharmacol Ther. 2005 Oct;108(1):94-108
pubmed: 16083966
Biochem Biophys Rep. 2020 Aug 11;23:100795
pubmed: 32817883
Hum Vaccin Immunother. 2015;11(2):458-67
pubmed: 25692880
Protein Sci. 2011 Aug;20(8):1439-50
pubmed: 21674662
Biochemistry. 2010 Dec 28;49(51):10831-41
pubmed: 21050007
Drug Metab Dispos. 2014 Jul;42(7):1125-31
pubmed: 24733787